BROUGHT
TO YOU BY
ASSOCIATE
SPONSORS
Monday, July 6, 2015 | Latest E-book
You are here:
Sun Pharma
#

Sun Pharma

Articles

Greece bailout hope: Sensex ends 136 points higher on late buying

Jun 30, 2015

Greece bailout hope: Sensex ends 136 points higher on late buying

Market breadth ended positive with 1,730 stocks ending in the gainers list as against 960 losers on BSE. #Sensex #Tata Steel #nifty #Debt #Sun Pharma #Greece #European Union #BSE #Lupin
Sensex ends down 167 points, after crashing over 600 pts in initial trades

Jun 29, 2015

Sensex ends down 167 points, after crashing over 600 pts in initial trades

Asian indices such as Nikkei, Hang Seng ended nearly 2-3 percent lower, while European gauges such as FTSE, DAX and CAC had crashed around 2-3.6 percent in early trades. #Sensex #Infosys #Bharti Airtel #wipro #nifty #Tata Motors #Sun Pharma #Greece #ONGC #BSE #Maruti Suzuki #BHEL #Debt crisis #MarketClose
AstraZeneca India shares zoom 20% after launch of type-2 diabetes drug

Jun 11, 2015

AstraZeneca India shares zoom 20% after launch of type-2 diabetes drug

Over 1 lakh shares changes hands on BSE so far against two week daily average volume of 17,000 shares #Sun Pharma #BSE #Diabetes #AstraZeneca Pharma India
After Maggi, are Starbucks, Kellogs next? FSSAI new blacklist targets many others

Jun 10, 2015

After Maggi, are Starbucks, Kellogs next? FSSAI new blacklist targets many others

Apart from Starbucks and Kellog's, other products in the list include Ranbaxy's Revittal capsules and Sun Pharma's Anofer tablets #Sun Pharma #Ranbaxy #Tata Starbucks #kellogs #FSSAI blacklist
Sun Pharma reports Q4 net profit at Rs 888 cr, Ranbaxy deal shrinks earnings

May 29, 2015

Sun Pharma reports Q4 net profit at Rs 888 cr, Ranbaxy deal shrinks earnings

Net sales of the company stood at Rs 27,286.50 crore for the year ended March 31. The same stood at Rs 16,004.39 crore in the last year. #Business #Ranbaxy Laboratories #Sun Pharma #BSE #EarningsShow #corporate
Sun Pharma maybe willing to shell out $7 bn on further acquisitions

Apr 28, 2015

Sun Pharma maybe willing to shell out $7 bn on further acquisitions

Sun Pharmaceuticals Industries, emboldened by its takeover of domestic rival Ranbaxy Laboratories, is willing to spend as much as $7 billion on further acquisitions, bankers familiar with the generic drugmaker's strategy said. #Sun Pharma #Ranbaxy #Dilip Shanghvi #drugmaker
Daiichi Sankyo's misery ends, block deal to give company coup de grce

Apr 22, 2015

Daiichi Sankyo's misery ends, block deal to give company coup de grce

Even after allowing for control premium, the price that Daiichi Sankyo paid for Ranbaxy Laboratories was clearly excessive, and those in the know said sagely that winners curse would have its say sooner than later. #Ranbaxy Laboratories #Sun Pharma #CompanyWatch #Daiichi Sankyo #Diageo #USFDA #United Spirits #Dilip Sanghvi